Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma
/in Colorectal Cancer, International Publications /von 2007-12-03 / Immunol. Lett. 2008 Feb;116(1):24-32[The anti-tumor efforts of thymosin alpha1 on tumor lysate-pulsed dendritic cells in colon cancer in vitro and in vivo]
/in Colorectal Cancer, International Publications /von 2007-11-01 / Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007 Nov;23(11):1046-9Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2007-11-01 / Int J Hyperthermia 2007 Nov;23(7):591-8Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell vaccines
/in Colorectal Cancer, International Publications /von 2007-10-01 / Cancer 2007 Oct;110(7):1469-77Fever-range whole body hyperthermia increases the number of perfused tumor blood vessels and therapeutic efficacy of liposomally encapsulated doxorubicin
/in Colorectal Cancer, Hyperthermia, International Publications /von 2007-09-01 / Int J Hyperthermia 2007 Sep;23(6):513-27Dendritic cell vaccination
/in Breast Cancer, Colorectal Cancer, Hypernephroma, International Publications, Malignant Melanoma, Prostate Cancer /von 2007-08-01 / Expert Rev Vaccines 2007 Aug;6(4):617-33Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine
/in Colorectal Cancer, International Publications /von 2007-04-18 / Cancer Immunol. Immunother. 2007 Oct;56(10):1597-604A study of dendritic and endothelial cell interactions in colon cancer in a cell line and small mammal model
/in Colorectal Cancer, International Publications /von 2007-02-20 / Eur J Surg Oncol 2007 Dec;33(10):1191-8A novel dendritic cell-based cancer vaccine produces promising results in a syngenic CC-36 murine colon adenocarcinoma model
/in Colorectal Cancer, International Publications /von 2007-02-01 / J. Surg. Res. 2007 May;139(2):164-9
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution